Chris McCausland gives verdict on taking part in Dancing On Ice after becoming first blind Strictly winner
The 47-year-old comedian - who lost his sight when he was 22 due to hereditary condition Retinitis Pigmentosa - became the ...
Hosted on MSN7h
Jones Trading Initiates Coverage of ProQR Therapeutics N.V. (PRQR) with Buy Recommendation
Fintel reports that on February 12, 2025, Jones Trading initiated coverage of ProQR Therapeutics N.V. (NasdaqCM:PRQR) with a ...
Watch: Jasmine Aji’s Neyyappams are a symbol of resilience
Resilient couple overcomes health challenges to build successful Neyyappam business, symbolizing hope and perseverance in Kerala.
KALA BIO Announces Chief Executive Officer Transition
Mr. Iwicki stated, “I am proud of the work we have done at KALA utilizing our MSC-S platform, and I am very excited about the potential of our lead product candidate, KPI-012 for the treatment of PCED ...
KALA BIO, Inc.: KALA BIO Announces Chief Executive Officer Transition
KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...
Hosted on MSN6h
Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction
Shares of Kala Bio Inc. tumbled over 35% on Wednesday, on track for their worst single-day decline ever, after the company ...
GlobalData on MSN12h
GenSight’s Optic Neuropathy gene therapy sustains efficacy over five years
Patients who received a single injection of Lumevoq displayed sustained clinical recovery in a rare condition that can lead ...
Ocugen announces dosing completion in Phase 2 ArMaDa clinical trial
Ocugen (OCGN) announced that dosing is complete, ahead of schedule in the Phase 2 portion of the Phase 1/2 ArMaDa clinical trial for OCU410-a ...